Healthcare Industry News:  IGRT 

Devices Oncology

 News Release - May 4, 2007

Elekta to Supply Leading IGRT Solution to Vejle Hospital in Denmark

STOCKHOLM, Sweden--(HSMN NewsFeed)--Vejle hospital has selected Elekta (STO:EKTAB) to supply world leading technology for intensity modulated and image guided radiation therapy and two Elekta Synergy® systems will be installed during 2007 and 2008. Elekta Synergy allows the clinicians to visualize the target at the time of treatment, enabling more aggressive treatment of tumors with increased precision and accuracy while minimizing the risk of damage to surrounding healthy tissue. The order is valued at over SEK 30 M.

Image guided radiation therapy (IGRT) has during the last couple of years become standard for new deliveries of radiation therapy solutions and Elekta Synergy is being established as the reference system for this more precise and accurate method for radiating cancer tumors. Vejle is a modern hospital in the southern part of Jutland. When it was time to upgrade and increase treatment capacity at the oncology department, the hospital evaluated available technology and found Elekta Synergy to best meet the highly set criteria. Elekta Synergy makes it possible to precisely locate and position the tumors inside the patient on a day-to-day basis, which is an important advantage when treating many of the most common cancers such as prostate, breast and lung cancer. Based on high-resolution 3D images, the necessary fine adjustments are made in a matter of seconds while the patient is positioned in the treatment system.

"We have been working with Vejle hospital for many years and we are very pleased that they chose a solution from Elekta when it came to taking the next step in upgrading and expanding the hospital's radiation therapy facility. It's yet another proof of Elekta's leading position in advanced clinical solutions for cancer treatment and shows that Elekta can offer solutions that is very well adapted to today's customer demand", summarizes Lennart Ward, Ph.D., Business Unit Manager Nordic & Baltic countries at Elekta.

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world's largest supplier of oncology software.

Elekta's systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 2000 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.


Source: Elekta

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.